Synergistic killing in pancreatic cancer cell lines of the combination of a MEK inhibitor and DNA methylation inhibitor.

被引：0
|
作者：
Jeffries, Matlock Arizona
Kurkjian, Carla
机构：
[1] Univ Oklahoma Hlth Sci Ctr, Oklahoma City, OK USA
[2] Stephenson Canc Ctr SCRI, Oklahoma City, OK USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15025
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A MEK/PI3K/HDAC inhibitor combination therapy for KRAS mutant pancreatic cancer cells
    Ischenko, Irene
    Petrenko, Oleksi
    Hayman, Michael J.
    ONCOTARGET, 2015, 6 (18) : 15814 - 15827
  • [32] Synergistic effect of gemcitabine and a Dclk1 inhibitor on pancreatic cancer cell survival
    Kawamura, Daichi
    Takemoto, Yoshihiro
    Nishimoto, Arata
    Tanaka, Toshiki
    Hironaka, Yukari
    Yoshida, Kumiko
    Murakami, Junichi
    Kugimiya, Naruji
    Harada, Eijiro
    Ueno, Koji
    Hosoyama, Tohru
    Hamano, Kimikazu
    CANCER RESEARCH, 2017, 77
  • [33] Synergistic effect of combination of MEK and phosphatidylinositol 3-kinase inhibitor on cell death in human prostate cancer DU145 cells
    Kim, Yunlim
    Hwang, Jung Jin
    Park, Hongzoo
    Lee, Gil Nam
    You, Dalsan
    Jeong, In Gab
    Kim, Choung-Soo
    CANCER RESEARCH, 2012, 72
  • [34] The efficacy of a histone deacetylase inhibitor in combination with a MEK inhibitor in lung cancer cells harboring RAS mutations
    Yamada, Tadaaki
    Amann, Joseph M.
    Tanimoto, Azusa
    Taniguchi, Hirokazu
    Shukuya, Takehito
    Yano, Seiji
    Takayama, Koichi
    Carbone, David P.
    CANCER RESEARCH, 2018, 78 (13)
  • [35] Anti-Melanoma Activities of Haspin Inhibitor CHR-6494 Deployed as a Single Agent or in a Synergistic Combination with MEK Inhibitor
    Han, Lili
    Wang, Peiling
    Sun, Yang
    Liu, Sijing
    Dai, Jun
    JOURNAL OF CANCER, 2017, 8 (15): : 2933 - 2943
  • [36] Antitumor effect of Trametinib, a selective MEK inhibitor, in combination with 4-methylumbelliferone, a hyaluronic acid synthesis inhibitor, in Malignant pleural mesothelioma cell lines
    Cho, Hiroyuki
    Matsumoto, Seiji
    Fujita, Yoshiko
    Kuroda, Ayumi
    Hashimoto, Masaki
    Takuwa, Teruhisa
    Menjul, Toshi
    Sonobel, Makoto
    Kondo, Nobuyuki
    Datel, Hiroshi
    Hasegawa, Seiki
    CANCER RESEARCH, 2015, 75
  • [37] Rational combination of the IGF-1R/IR tyrosine kinase inhibitor (TKI), OSI-906, with the MEK inhibitor, U0126, results in synergistic and apoptotic effects in human colorectal cancer (CRC) cell lines
    Flanigan, Sara A.
    Pitts, Todd M.
    Kulikowski, Gillian N.
    Tan, Aik Choon
    Nallapareddy, Sujatha
    Tentler, John J.
    Eckhardt, S. Gail
    Leong, Stephen
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [38] The Telomerase Inhibitor Imetelstat Depletes Cancer Stem Cells in Breast and Pancreatic Cancer Cell Lines
    Joseph, Immanual
    Tressler, Robert
    Bassett, Ekaterina
    Harley, Calvin
    Buseman, Christen M.
    Pattamatta, Preeti
    Wright, Woodring E.
    Shay, Jerry W.
    Go, Ning F.
    CANCER RESEARCH, 2010, 70 (22) : 9494 - 9504
  • [39] Rational combination of pan-TEAD inhibitor SW-682 and MEK inhibitor mirdametinib in head and neck squamous cell carcinomas leads to synergistic response
    Schirmer, A.
    Chen, L.
    Celentano, L.
    Chanelo, A.
    Jove, V.
    DuBose, R.
    Saha, S.
    Johnson, M.
    Lawhorn, B.
    Gwaltney, S.
    Lin, T. A.
    de Marval, P. Miliani
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S90 - S91
  • [40] Combination of a supramolecular nanotherapeutic targeting MEK and immune checkpoint inhibitor exerts a synergistic antitumor outcome
    Kulkarni, Ashish A.
    Sabbisetti, Venkata
    Pandey, Prithvi Raj
    Sengupta, Shiladitya
    CANCER RESEARCH, 2015, 75
12345